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Received March 3, 2012; accepted June 11, 2012AbstractBackground: The most common serious complication following acute ischemic stroke is pneumonia, which may increase mortality and worsen
clinical outcomes. The purpose of this study was to investigate the predictors of 30-day mortality in patients with pneumonia following acute
ischemic stroke.
Methods: From June 2006 to May 2011, we retrospectively included 51 patients with pneumonia following acute ischemic stroke. We analyzed
the clinical features, microbiologic data, and outcomes. Predictors of 30-day mortality were investigated by univariate and multivariate analysis.
Results: The acute ischemic strokes were caused by large-artery atherosclerosis in 37 (72.5%) of the 51 patients. We found that the most
common pathogen responsible for poststroke pneumonia was Klebsiella pneumoniae, followed by Pseudomonas aeruginosa and Escherichia
coli. Ultimately, 12 patients died of progressive sepsis due to pneumonia after the acute ischemic stroke. The 30-day mortality rate was 23.5%. In
the univariate analysis, patients who died within 30 days had higher National Institutes of Health Stroke Scale scores, higher CURB-65 scores,
elevated instability of hemodynamic status, and lower Glasgow Coma Scale (GCS) scores. In Cox regression analysis, a GCS score of <9 on the
day of pneumonia onset was only significant indicator for 30-day mortality (hazard ratio, 6.72; 95% confidence interval, 2.12e21.30, p ¼ 0.001).
Conclusion: Pneumonia after acute ischemic stroke is a severe complication. Once stroke-related pneumonia develops, neurologic assessment,
CURB-65 score, and shock can be used to predict the ultimate prognosis.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Stroke is a major cause of mortality worldwide, particularly
in middle and upper income countries. In the last 5 years, it is
the third most common cause of death in Taiwan; the preva-
lence rate for stroke in 1986 in Taiwanese people 36 years of
age or older was 1642 per 100,000 and the incidence rate for
people aged 36 or older was 330 per 100,000.1,2 In 2008, 6.2* Corresponding author. Dr. Shih-Chieh Chang, Department of Internal
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http://dx.doi.org/10.1016/j.jcma.2012.10.005million people died of stroke or another form of cerebrovascular
disease.3 Although neurologic complications are the major
causes of mortality, up to one-half of all patients with acute
stroke may die of other medical complications, including
pulmonary infection.4 Among the non-neurologic complica-
tions of acute stroke, pneumonia is a common infective
complication with a reported frequency of 10e20%. Once
stroke-related pneumonia develops, the patients will usually
have poor clinical outcome including increased long-term
disability or mortality.4,5 One large cohort study reported that
stroke patients complicated with pneumonia had a three-fold
greater risk of 30-day mortality compared with those without
pneumonia, and the population-attributable risk was 10%.6hinese Medical Association. All rights reserved.
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risk-stratified prediction rules for prognosis including pneu-
monia severity index (PSI) and CURB-65 score provide
valuable predictive value for risk assessment and 30-day
mortality.7,8 For patients with higher PSI (class V) or
CURB-65 scores (4 or 5), the mortality rate is high (30e50%),
and the physicians should carefully assess the patients for
admission to intensive care units. However, limited research
has been done to establish prognostic factors for the outcome
of pneumonia following acute stroke.
In this study, we investigated the incidence of pneumonia
following acute ischemic stroke and described the major
identified pathogens. Furthermore, we analyzed the possible
predictive factors for 30-day mortality.2. Methods2.1. Study populationNational Yang-Ming University is a 400-bed regional
teaching hospital and offers clinical services in North Yilan
City. From June 2006 to May 2010, patients aged 18 years or
older who were admitted to National Yang-Ming Hospital due
to acute ischemic stroke were screened for eligibility for
inclusion in this study. Exclusion criteria included those aged
less than 18 years, those who died within 3 days after
admission for acute stroke, those with acute hemorrhagic
stroke, and those without chest plain film examinations upon
admission (Fig. 1). Neurologic status was assessed on a daily
basis using the National Institutes of Health Stroke Scale
(NIHSS). The final infarct location was determined using
cranial computed tomography or magnetic resonance imaging.
The diagnosis of stroke was confirmed based on previously
published and generally accepted clinical criteria.9 Essentially,
stroke was diagnosed if there was a new onset of neurologic
deficits, corresponding to a vascular origin in the brain lasted
for more than 24 hours. The subtype of acute ischemic stroke
was classified according to the Trial of Org 10172 in Acute
Stroke Treatment (TOAST).10Fig. 1. Flowchart of patients with stroke-associated pneumonia.Pneumonia following stroke during the same hospitaliza-
tion was diagnosed according to Centers for Disease Control
and Prevention criteria.11 Briefly, pneumonia was diagnosed if
the patient had relevant clinical manifestations (fever, leuko-
cytosis, or purulent tracheal secretion), positive microbiologic
findings (blood, sputum cultures), and a new onset of
pulmonary infiltrates on chest radiography. This information
was submitted to a review committee comprised of two radi-
ologists and two pulmonologists to confirm the diagnosis of
pneumonia. The study was approved by the Institutional
Review Board. Written informed consent was waived due to
the retrospective design of the study.2.2. Clinical dataDemographic, laboratory, and radiologic data of the study
population were obtained from medical record records. Patient
records for at least 30 days were reviewed unless death had
previously occurred. The demographic data included age, sex,
comorbidity, smoking history, and the Glasgow Coma Scale
(GCS)12 at the initial presentation of stroke and pneumonia.
For each patient, the time from acute ischemic stroke to
pneumonia was recorded. Laboratory data, including complete
blood cell with differential counts, C-reactive protein (CRP),
biochemistry, oxyhemoglobin saturation measured by pulse
oximetry (SpO2), and arterial blood gas analysis, were
reviewed. The severity of pneumonia was assessed by PSI and
CURB-65 score, and the PSI score based on age and coex-
isting disease, abnormal physical finding, and abnormal
laboratory finding upon presentation.7 The CURB-65 score
based on confusion, urea, respiratory rate, blood pressure, and
age at pneumonia presentation.8 The causative microorganism
of pneumonia was identified if the pathogen was isolated
through blood culturing or pleural effusion. The predominant
pathogen isolated from a sputum culture that corresponded to
a Gram stain of the same sputum specimen was also consid-
ered to be a causative microorganism. Shock was defined as
systolic blood pressure less than 90 mmHg for at least 30
minutes, which required vasopressor for at least 4 hours after
adequate fluid replacement.132.3. Radiologic analysisBrain computed tomography and magnetic resonance
images and chest plain films were reviewed independently by
two radiologists who were blinded to the clinical and epide-
miologic data.2.4. Statistical analysisStatistical analyses were performed using SPSS software
version 15.0 (SPSS Inc., Chicago, IL, USA). In each group,
the patient data were described by frequency for categorical
variables, and by mean  standard deviation (SD) for numeric
variables. The time from the day of stroke to pneumonia onset
was described by median and range. Categoric variables were
compared using the Chi-square test or Fisher’s exact test, and
Table 2
Etiologies of pneumonia.
Pathogen Sputum (n) Blood (n) Total (n)
Klebsiella pneumoniae 12 12
Pseudomonas aeruginosa 4 1 5
Escherichia coli 5 5
Haemophilus influenzae 3 3
Acinetobacter baumannii 2 1 3
Staphylococcus aureus 3 3
Enterococcus species 2 2
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unpaired t test and the Mann-Whitney U test if not normally
distributed. Univariate analysis was performed to evaluate
prognostic factors for 30-day mortality and Cox regression
analysis was used to identify the predictors of 30-day
mortality. A two-tailed p value <0.05 was considered to be
statistically significant.
3. Results
Enterobacter cloaca 1 1
Streptococcus species 1 1
Achromobacter species 1 1
3.1. Patient characteristicsStenotrophomonas maltophilia 1 1
Aeromonas jandaei 1 1From June 2006 to May 2010, 495 patients who were
admitted due to acute ischemic stroke were included for
further screening. Of these patients, 51 were diagnosed with
pneumonia following stroke. The frequency of pneumonia
following acute ischemic stroke was 10.3%.
The mean age of the 51 patients was 80.3 years and 37
(72.5%) were male. According to the TOAST classification,
the acute ischemic strokes were due to large-artery athero-
sclerosis in 37 (72.5%) of the patients, followed by small
vessel occlusion (n ¼ 11, 21.6%), cardioembolism (n ¼ 2,
3.9%), and undetermined etiology (n ¼ 1, 2.0%). The demo-
graphic data of the patients are summarized in Table 1. The
most common comorbidity was hypertension (70.6%).
The median time from stroke to pneumonia was 4.4 days
(range: 0e23 days). In 27 (52.9%) patients, pneumonia
occurred in the first 3 days after stroke occurred.3.2. Microbiologic diagnostic data of pneumoniaThe microbiologic data of poststroke pneumonia are
summarized in Table 2. The most common causative pathogenTable 1
Demographic data of patients with pneumonia after acute stroke (n ¼ 51).
Age, y (mean  SD) 80.3  8.2
Range (59e95)
Male sex, n (%) 37 (72.5)
Smoking history 22 (43.1)
Comorbidities
Hypertension 30 (70.6)
Previous stroke 16 (31.4)
Diabetes mellitus 15 (29.4)
Heart failure 14 (27.5)
COPD 13 (25.5)
Chronic kidney disease 6 (11.8)
Alcoholism 4 (7.8)
Malignancy 3 (5.9)
Liver cirrhosis 2 (3.9)
Characteristics of ischemic stroke
Initial Glasgow Coma Scale (mean  SD) 11.8  3.0
NIHSS (mean  SD) 15.5  10.1
TOAST classification
Large-artery atherosclerosis 37 (72.5)
Small-vessel occlusion 11 (21.6)
Cardioembolism 2 (3.9)
Stroke of undetermined etiology 1 (2.0)
COPD ¼ chronic obstructive pulmonary disease; NIHSS ¼ National Institutes
of Health Stroke Scale; TOAST ¼ Trial of Org 10172 in Acute Stroke
Treatment.was Klebsiella pneumoniae (n ¼ 12), followed by Pseudo-
monas aeruginosa (n ¼ 5) and Escherichia coli (n ¼ 5).3.3. Patient outcomesThe most common classification of PSI upon diagnosis of
pneumonia was class IV (n ¼ 23, 45.1%), followed by class V
(n ¼ 22, 43.1%) and class III (n ¼ 5, 9.8%). All patients
received intravenous antibiotic treatment once pneumonia was
diagnosed. Twelve patients died and the 30-day mortality rate
was 23.5%. Regarding causes of death, 12 patients died of
progressive sepsis due to pulmonary infection. The 30-day
mortality rate according to the PSI classification was 36.4%
(class V), 17.4% (class IV), and 0% (class III).
Of these patients, the CURB-65 scores are as follows: 1
(n ¼ 5, 9.8%), 2 (n ¼ 17, 33.3%), 3 (n ¼ 24, 40.1%), and 4
(n ¼ 5, 9.8%). The 30-day mortality rate for each CURB-65
score was 60% (score ¼ 4), 29.2% (score ¼ 3), 11.8%
(score ¼ 2), and 0% (score ¼ 1).
The most common presentation on the chest radiograph
was unilateral alveolar consolidation (56.9%). There were no
statistically significant imaging pattern for the survival and
nonsurvival groups (Table 3).
The empirical antibiotics were classified as respiratory
fluoroquinolone (levofloxacin), b-lactam (cefazolin, cefurox-
ime, cefoxitin, ceftriaxone, and ampicillin-sulbactam), and
antipseudomonal b-lactam (ceftazidime and piperacillin-
tazobactam). There were no statistical significance in initial
antibiotic selection between the groups (Table 3).3.4. Univariate and Cox regression analysis for 30-day
mortalityIn univariate analysis, higher National Institutes of Health
Stroke Scale scores, CURB-65 scores  3, lower GCS scores
on the day of pneumonia onset, and shock were the predic-
tors of 30-day mortality (Table 3). In Cox regression analysis
(Table 4), a GCS score of less than 9 on the day of pneu-
monia onset was only significant indicator for 30-day
mortality (hazard ratio, 6.72; 95% confidence interval,
2.12e21.30; p ¼ 0.001).
Table 4
Cox regression analysis for predictor of 30-day mortality.
Variables Hazard ratio 95% confidence
intervals
p
GCS<9 (pneumonia) 6.72 2.12 e 21.30 0.001
Age75 NA NA 0.301
Male sex NA NA 0.176
Shock NA NA 0.059
CURB-653 NA NA 0.481
GCS ¼ Glasgow Coma Scale; NA ¼ not applicable.
Table 3
Univariate analysis of survivors and nonsurvivors (n ¼ 51).
Survivors (n ¼ 39) Non-survivors (n ¼ 12) p
Age, y (mean  SD) 79.9  8.7 81.6  6.4 0.550
Male sex 31 (79.5) 6 (50.0) 0.066
Smoking history 18 (46.2) 4 (33.3) 0.433
Diabetes mellitus 12 (30.8) 3 (25.0) 1.000
Hypertension 29 (74.4) 7 (58.3) 0.302
Chronic kidney disease 5 (12.8) 1 (8.3) 1.000
Previous stroke 13 (33.3) 3 (25.0) 0.730
COPD 12 (30.8) 1 (8.3) 0.151
Congestive heart failure 9 (23.1) 5 (41.7) 0.272
NIHSS (mean  SD) 13.1  9.2 (n ¼ 25) 23.0  9.8 (n ¼ 8) 0.014
Large-artery atherosclerosis 26 (66.7) 11 (91.7) 0.142
GCS (stroke) (mean  SD) 12.0  3.1 11.3  3.1 0.461
GCS (pneumonia) (mean  SD) 11.5  3.2 (n ¼ 38) 8.2  2.9 0.002
Dysarthria score in retrograde NIHSS (mean  SD) 1.28  0.8 (n ¼ 25) 1.75  0.5 (n ¼ 8) 0.058
Time from stroke to pneumonia, d (mean  SD) 4.4  4.1 4.5  4.9 0.921
Body temperature (C) (mean  SD) 37.9  1.0 38.1  0.8 0.580
Heart rate (mean  SD) 102.9  20.6 109.8  31.2 0.376
Respiratory rate (mean  SD) 23.1  5.0 26.4  6.2 0.059
Systolic blood pressure (mean  SD) 149.0  34.5 125.0  38.9 0.046
WBC count, /mm3 (mean  SD) 11641.8  4199.7 10885.0  3960.1 0.583
Hemoglobin, g/dL (mean  SD) 12.1  2.2 11.2  2.2 0.207
Platelet count, K/mm3 (mean  SD) 208.7  72.5 194.8  85.2 0.579
CRP (mean  SD) 10.3  10.3 (n ¼ 33) 6.7  5.7 (n ¼ 10) 0.160
Albumin (mean  SD) 3.4  0.5 (n ¼ 16) 3.4  0.5 (n ¼ 6) 0.782
Blood urea nitrogen, mg/dL (mean  SD) 25.8  14.0 30.5  21.9 0.382
Serum creatinine, mg/dL (mean  SD) 1.5  1.4 2.0  3.7 0.466
Serum sodium, mg/dL (mean  SD) 137.4  3.5 136.1  8.1 0.607
PSI class (mean  SD) 4.3  0.7 4.7  0.5 0.058
PSI classes IVeV 15 (38.5) 8 (66.7) 0.086
CURB-65 (mean  SD) 2.4  0.8 3.1  0.7 0.010
Higher CURB-65 score (3-5) 19 (48.7) 10 (83.3) 0.034
APACHE II (mean  SD) 18.9  7.7 (n¼19) 17.6  6.1 (n¼8) 0.682
ICU admission 19 (48.7) 9 (75.0) 0.110
Invasive mechanical ventilation 8 (21.1) 4 (33.3) 0.448
Non-invasive mechanical ventilation 3 (7.9) 0 (0.0) 1.000
Shock requiring vasopressor 2 (5.1) 4 (33.3) 0.022
Multilobar involvement 15 (38.5) 7 (58.3) 0.224
Pleural effusion 3 (7.7) 1 (8.3) 1.000
Atelectasis 0 (0.0) 2 (16.7) 0.052
Empirical antibiotics
Initial antibiotics covering anaerobic 23 (59.0) 7 (63.6) 1.000
Respiratory fluoroquinolone 3 (7.7) 0 (0.0) 0.322
b-lactam 27 (69.2) 10 (83.3) 0.338
Anti-pseudomonalb-lactam 9 (23.1) 2 (16.7) 0.637
APACHE ¼ Acute Physiology And Chronic Health Evaluation; COPD ¼ chronic obstructive pulmonary disease; CRP ¼ C-reactive protein; GCS ¼ Glasgow
Coma Scale; ICU ¼ intensive care unit; NIHSS ¼ National Institutes of Health Stroke Scale; PSI ¼ Pneumonia Severity Index.
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Stroke and the poststroke states are the most significant risk
factors for aspiration pneumonia. Thorough preventive and
therapeutic strategies have been developed, and appropriate
antibiotic use, both pharmacologic and nonpharmacologic
approaches for the treatment of poststroke pneumonia, have
been rigorously studied. Increases in substance P levels, oral
care, and swallowing rehabilitation are necessary to improve
the swallowing function in poststroke patients, resulting in
a reduction in the incidence of poststroke pneumonia at
a chronic stage. Therefore, stroke is a cause of aspiration
pneumonia.14
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tered and has a significantly deleterious effect on clinical
outcomes, there is no useful predictive investigative tool for this
clinical entity. For community-acquired pneumonia, PSI and
CURB-65 have been well-validated and widely used in severity
classification, and many clinicians use them as a guide to appro-
priately manage patients with community-acquired pneumonia.
We found that patients with a semi-coma status (GCS<9), higher
CURB-65 score, and unstable hemodynamic status had worse
short-term survival.
There is a strong rationale for investigating the efficacy of
preventive antibiotics in patients with acute stroke. Antibi-
otics can be used after acute stroke to prevent infection and
may also offer neuroprotection. To prevent infections,
the antimicrobial spectrum should cover the most
common causative bacteria of pneumonia and urinary
tract infections. Streptococcus pneumoniae, Haemophilus
influenzae, Staphylococcus aureus, and Enterobacteriaceae
predominate in patients with aspiration pneumonia, and
occur within 4 days after admission (community-acquired
aspiration syndrome).15
In our study, the predominant etiology responsible
for poststroke pneumonia was Gram-negative bacilli
(K. pneumoniae, Pseudomonas aeruginosa, and Escherichia
coli). In a study by Hassan et al, Gram-negative bacilli such
as P. aeruginosa (12%) and K. pneumoniae (4%) were, for
the most part, the causative microorganisms in stroke-
associated pneumonia.16 For this reason, the initial choice
of empirical antibiotics may be based on nosocomial
infection.
Although the aspiration of oropharyngeal secretion is
considered to be the major pathogenesis of stroke-
associated pneumonia,17 we did not find that initial anti-
biotics with anaerobic coverage improved 30-day mortality.
Anaerobic pathogens were also infrequently isolated from
sputum, pleural fluid or blood in a previous clinical
survey.16
There are several limitations to our study. One major
limitation is the relatively small sample size and the retro-
spective nature. Second, some potential biomarkers that
predict the outcome of pneumonia, such as the serum pro-
calcitonin level,18 were not used in this study. Another limi-
tation of the study is that these prognostic factors should be
validated in another stroke patient cohort. Nevertheless, these
clinical factors may be used to guide treatment strategy,
including intensive care, mechanical ventilation, and admin-
istration of broad-spectrum antibiotics.
In conclusion, pneumonia is a severe complication of acute
ischemic stroke. Once pneumonia develops, an immediate
assessment of the GCS, CURB-65 score, and hemodynamic
status may help to predict the short-term outcomes.Acknowledgments
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